Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Melarsoprol

EU orphan designation number: EU/3/12/1068   
Active ingredient: Melarsoprol
Indication: Treatment of African trypanosomiasis
Sponsor: Pr. Peter Kennedy
Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Centralised Orphan - Designation EMA/OD/116/12 (2012)8202 of 08/11/2012